Market Overview - The personal care products sector experienced a decline of 1.23% on February 2, with Yanjiang Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4015.75, down 2.48%, while the Shenzhen Component Index closed at 13824.35, down 2.69% [1] Stock Performance - Notable gainers in the personal care sector included: - Beijiajie (603059) with a closing price of 38.70, up 3.78% on a trading volume of 80,800 shares and a transaction value of 308 million yuan [1] - Zhiya Co., Ltd. (003006) closed at 21.34, up 2.99% with a trading volume of 86,300 shares and a transaction value of 184 million yuan [1] - Dengkang Oral (001328) closed at 40.88, up 2.58% with a trading volume of 31,500 shares and a transaction value of 129 million yuan [1] - Major decliners included: - Yanjiang Co., Ltd. (300658) closed at 15.81, down 12.17% with a trading volume of 418,300 shares and a transaction value of 686 million yuan [2] - Zhongshun Jiesang (002511) closed at 7.92, down 2.82% with a trading volume of 277,300 shares and a transaction value of 223 million yuan [2] Capital Flow - The personal care products sector saw a net outflow of 114 million yuan from institutional investors, while retail investors experienced a net inflow of 28.68 million yuan [2] - The capital flow for key stocks in the sector included: - Haoyue Nursing (605009) had a net inflow of 2.75 million yuan from institutional investors, but a net outflow of 2.32 million yuan from retail investors [3] - Beijiajie (603059) saw a net inflow of 2.44 million yuan from institutional investors and a net outflow of 17.41 million yuan from retail investors [3] - Yanjiang Co., Ltd. (300658) experienced a significant net outflow of 13.22 million yuan from institutional investors [3]

Investment Rating - The industry rating is "Recommended" [5] Core Insights - Anta announced on January 26, 2026, the acquisition of 29.06% of Puma SE for a total of €1.506 billion (approximately ¥12.278 billion), becoming its largest shareholder. This transaction is a key step in Anta's globalization strategy, aiming to integrate its operational capabilities with Puma's global platform, which has an annual revenue exceeding €8.8 billion (2024) [2][14] - Adidas achieved a record high revenue of €24.811 billion in 2025, with operating profit of €2.056 billion exceeding market expectations. The operating profit margin increased by 2.6 percentage points to 8.3%, and the gross profit margin rose to 51.6% [2][14] - VF Corporation reported a revenue of $2.82 billion in Q3 of FY2026, a 4% year-on-year increase (2% growth at constant currency), with a 6% growth in the Americas region after excluding the impact of the sold Dickies brand [3][14] Summary by Sections Investment Recommendations - Manufacturing: Strong expectations for upstream price increases, with wool prices rising since Q3 2025 and domestic cotton prices also starting to rise. Recommended stocks include Baolong Oriental, New Australia, and Fuchun Dyeing & Weaving, with beneficiaries being Taihua New Materials. For growth-oriented midstream, recommended stocks are Jiansheng Group and Kairun Co [3][15] - Brand: Recent signs of recovery in high-end consumption, with potential inflation in 2026 benefiting the consumer sector. Recommended brands with profit elasticity include Jinhong Group, Ge Li Si, Luolai Life, and Stable Medical [3][15] - Procter & Gamble's industrial chain: Recommended stocks include Jieya Co (benefiting from brand-owned capacity transfer), with beneficiaries being Yanjing Co [3][15] Market Review - The SW textile and apparel sector rose by 0.64%, outperforming the Shanghai Composite Index by 1.08%. The top five gainers in the sector included Harsen Co, Zhongwang Fabric, Hongda High-Tech, Mingxin Xuteng, and Aokang International [16] - The main inflow of funds was into Harsen Co, with a net inflow ratio of 10.10%, while the largest outflow was from Sanfu Outdoor, with a net outflow ratio of 4.59% [16][22] Industry Data Tracking - Wool prices increased by 2.49% this week, with a year-to-date increase of 41.94%. The Australian wool market index reached 1689 AUD cents/kg, equivalent to ¥82,085.40/ton [4][35] - The cotton price index in China rose by 3.84% year-to-date, with the 3128B index at ¥16,183/ton [30][32] - In 2025, textile and apparel exports decreased by 2.26% year-on-year, with total exports amounting to $267.79 billion [52]

Investment Rating - The industry rating is "Recommended" [5] Core Insights - Anta announced on January 26, 2026, the acquisition of 29.06% of Puma SE for a total of €1.506 billion (approximately ¥12.278 billion), becoming its largest shareholder. This transaction is a key step in Anta's globalization strategy, aiming to integrate its operational capabilities with Puma's global platform, which has an annual revenue exceeding €8.8 billion (2024). The deal requires multiple approvals by December 31, 2026, including antitrust and Anta's shareholder meeting [2][14] - Adidas achieved a record high revenue of €24.811 billion in 2025, with an operating profit of €2.056 billion, exceeding market expectations of €2.04 billion. The operating profit margin increased by 2.6 percentage points to 8.3%, and the gross profit margin rose to a high of 51.6% for the year [2][14] - VF Corporation reported a revenue of $2.82 billion in Q3 of fiscal 2026, excluding the impact of the sold Dickies brand, representing a year-on-year growth of 4% (2% growth at constant currency). In the Americas, revenue growth reached 6% after excluding Dickies [3][14] Summary by Sections Investment Recommendations - Manufacturing: Strong expectations for upstream price increases, with wool prices rising since Q3 2025 and domestic cotton prices also starting to increase. Recommended stocks include Baolong Oriental, New Australia, and Fuchun Dyeing & Weaving, with beneficiaries being Taihua New Materials. For growth-oriented midstream, recommended stocks are Jian Sheng Group and Kairun Co [3][15] - Brand: Recent signs of recovery in high-end consumption, with potential inflation in 2026 benefiting the consumer sector. Recommended brands with profit elasticity include Jinhong Group, Ge Li Si, Luolai Life, and Stable Medical [3][15] - Procter & Gamble's industrial chain: Recommended stocks include Jieya Co (benefiting from brand-owned capacity transfer), with beneficiaries being Yanjing Co [3][15] Market Review - The SW textile and apparel sector rose by 0.64%, outperforming the Shanghai Composite Index by 1.08% and the ChiNext Index by 0.73%. The top-performing sectors were footwear, home textiles, and textile machinery, while the worst performers were maternal and child products and high-end women's wear. The top five stocks by increase were Harsen Co, Zhongwang Fabric, Hongda High-Tech, Mingxin Xuteng, and Aokang International, while the top five by decrease were Shuhua Sports, Sanfu Outdoor, Langzi Co, Nanshan Zhishang, and Mengjie Co [16] Industry Data Tracking - Wool prices increased by 2.49% this week, with a year-to-date increase of 41.94%. As of January 22, 2026, the Australian wool market's eastern market composite index was 1689 AUD cents/kg, equivalent to ¥82,085.40/ton. This price increase began in July 2025 and has accelerated since then, with the index rising for 12 consecutive weeks [4][35] - The cotton price index in China rose by 3.84% year-to-date, with the 3128B index at ¥16,183/ton as of January 30, 2026 [30][32] - In 2025, textile and apparel exports totaled $267.79 billion, a year-on-year decrease of 2.26%. December exports were $25.992 billion, down 7.4% year-on-year but up 13.65% month-on-month [52]

Core Insights - The A-share market experienced fluctuations with the Shanghai Composite Index falling by 0.96% to 4117.95 points, while the Shenzhen Component Index decreased by 0.66%. The ChiNext Index, however, rose by 1.27% [1][7] - The total trading volume in the A-share market was 2.86 trillion RMB, with nearly 2900 stocks declining. The communication sector led the gains, while the non-ferrous metals sector saw the largest losses [1][7] - In the Hong Kong market, the Hang Seng Index dropped by 2.08%, and the Hang Seng Tech Index fell by 2.1%. In the overseas markets, all three major U.S. stock indices declined, with the Dow Jones down by 0.36%, the S&P 500 down by 0.43%, and the Nasdaq down by 0.94% [1][7] Important News - The Central Committee of the Communist Party of China emphasized the acceleration of the new round of technological revolution and industrial transformation, highlighting the importance of leveraging comparative advantages to promote breakthroughs in future industries [2][8] - The National Bureau of Statistics reported that the manufacturing PMI for January was 49.3%, a decrease of 0.8 percentage points month-on-month. The non-manufacturing PMI also fell to 49.4%, indicating a decline in business activity due to seasonal factors and insufficient market demand [2][8] Sector Analysis - In the social services sector, the proportion of heavy positions in funds increased, with 286 funds holding shares, up by 109 from the previous quarter. The total market value of holdings reached 5.57 billion RMB, an increase of 0.975 billion RMB [9][10] - The heavy position ratio for the social services sector was 0.06%, up by 0.01 percentage points, ranking 27th among 31 sectors, indicating potential for rebound as it remains below the 5-year average of 0.34% [9][10] - The hospitality and restaurant sectors showed slight recovery, while the education sector saw a significant decline in heavy position ratios [9][10] Individual Stocks - Leading stocks in the social services sector saw increased holdings, with the top ten stocks' combined heavy position ratio rising to 0.058%, an increase of 0.013 percentage points from the previous quarter. Notable stocks include Huace Testing, Shoulv Hotel, and JiuHua Tourism [10][11] - The report suggests focusing on companies benefiting from the upcoming long holiday and those positioned to take advantage of the Hainan Free Trade Port's opportunities [11] Beauty and Personal Care Sector - The beauty and personal care sector saw a decrease in fund allocation, with the total market value of A-shares at 255.096 billion RMB, down by 10.43% from the previous quarter. The fund allocation ratio was 0.14%, a decrease of 0.06 percentage points [12][13] - The personal care and cosmetics segments remain in a low allocation zone, while the medical beauty segment is in an over-allocated position [12][13] - Key stocks in the beauty and personal care sector include Jinbo Biological, Aimeike, and Baiya Shares, with their heavy position ratios declining compared to the previous quarter [14]

Group 1 - The core concept of surgical infection control (SIC) involves a systematic infection prevention and control system throughout the surgical process, including preoperative assessment, sterile procedures during surgery, and postoperative wound care [1][8] - The SIC industry value chain consists of upstream components like disinfection materials and medical supplies, midstream focusing on product manufacturing and service integration, and downstream connecting to various healthcare institutions [1][10] - The demand for SIC is expected to rise due to the increasing number of surgeries in China, projected at approximately 96.39 million surgeries in 2023 [11] Group 2 - The global SIC market surpassed 20 billion yuan in 2019 and is projected to reach 27.06 billion yuan by 2026, growing at an annual rate of 4-5% [2][14] - China's SIC export market has grown significantly, reaching 740 million USD in 2023, with expectations to reach 1.078 billion USD by 2026 [2][17] - Major companies in the SIC industry include Aomei Medical, Zhend Medical, Jianerkang, and Aisheren Medical, with a predominant focus on overseas sales [2][20] Group 3 - The research team from Huajing Industry Research Institute employs various analytical models to assess the SIC industry's market capacity, competitive landscape, and future trends [3][27] - The report titled "2026-2032 China Surgical Infection Control Industry Market Research and Investment Opportunity Assessment" provides insights for enterprises and investment institutions [3][27] - The SIC industry is characterized by a combination of OEM and ODM business models, with some companies transitioning to self-branded sales [2][20]

Market Overview - The personal care products sector experienced a decline of 1.66% on January 30, with Zhongshun Jierou leading the drop [1] - The Shanghai Composite Index closed at 4117.95, down 0.96%, while the Shenzhen Component Index closed at 14205.89, down 0.66% [1] Stock Performance - The following stocks in the personal care sector showed notable performance: - Beijiajie (603059) increased by 10.00% to a closing price of 37.29, with a trading volume of 32,300 hands and a turnover of 118 million [1] - Reliable Co. (301009) rose by 1.21% to 13.38, with a trading volume of 32,700 hands and a turnover of 43.52 million [1] - Liangmian Needle (600249) saw a slight increase of 0.51% to 5.92, with a trading volume of 112,700 hands and a turnover of 66.34 million [1] - Zhongshun Jierou (002511) fell by 5.45% to 8.15, with a trading volume of 482,800 hands and a turnover of 400 million [2] Capital Flow - The personal care products sector experienced a net outflow of 105 million from institutional investors, while retail investors saw a net inflow of 42.76 million [2] - The following stocks had significant capital flow: - Beijiajie (603059) had a net inflow of 20.94 million from institutional investors, but a net outflow of 15.94 million from retail investors [3] - Zhongshun Jierou (002511) faced a net outflow of 21.64 million from institutional investors [3] - Reliable Co. (301009) had a minor net inflow of 0.57 million from institutional investors [3]

每经头条（nbdtoutiao）——核电建设热潮下，设备厂忙到"飞起"！订单已排至2028年，员工三班倒， 产线24小时不停 每经AI快讯，稳健医疗发布公告称，2026年1月29日，稳健医疗接受国信证券等投资者调研，公司副总 经理、董事会秘书陈惠选等人参与接待，并回答了投资者提出的问题。 （记者 王晓波） ...

Core Viewpoint - The company, Steady Medical, has reported rapid growth in its high-end dressing segment within its medical business, indicating a strong potential for future expansion in both domestic and international markets [1] Group 1: Business Performance - The high-end dressing category is identified as a strategic product line with significant growth [1] - The gross profit margin for this segment is relatively high, contributing positively to the company's financial health [1] Group 2: Market Dynamics - The overseas market for high-end dressings has reached a mature stage, suggesting established demand and competitive positioning [1] - The domestic market is still in the promotion phase, indicating substantial room for growth and market penetration in the future [1]

Group 1: Medical Sector Overview - The medical business under the "Winner" brand includes traditional wound care, high-end dressings, surgical consumables, infection protection, and personal health products. High-end dressings are experiencing rapid growth, particularly in overseas markets, while domestic markets are still in the promotion phase, indicating significant future potential [1][2]. - The medical sector is driven by both organic growth and external acquisitions, maintaining a steady upward development trend [2]. Group 2: Profitability and Future Outlook - The medical sector's profitability is recovering post-public health events, with fluctuations observed from 2020 to 2024. A comprehensive integration and efficiency improvement strategy is expected to enhance profit margins, aiming to restore them to pre-2020 levels [3]. - Future profitability is anticipated to improve as the sector shifts towards high-end product structures and brand enhancement, with a focus on optimizing cost control [3]. Group 3: Strategic Acquisition of GRI - The acquisition of GRI brings strategic advantages, including access to quality channels and customer resources, a global production capacity across multiple countries, and significant product synergy that supports market expansion, particularly in the Americas [4]. Group 4: All Cotton Era's Competitive Advantages - All Cotton Era's core competitive advantages lie in its medical background, cotton philosophy, and quality gene, attracting a loyal customer base focused on safety and sustainability [5]. - The brand has implemented a successful product strategy and refined channel operations, leading to consistent revenue and profit growth [5]. Group 5: Differentiation and Market Position - All Cotton Era differentiates itself through its brand vision, product innovation, and channel layout, emphasizing the benefits of cotton and maintaining high production standards [6]. - The brand has developed a unique business model and achieved leading positions in several product categories, driving overall sales growth [6]. Group 6: Channel Strategy and Profitability - The channel strategy balances online and offline development, with online sales accounting for approximately 60% and offline for about 40% of total revenue [7]. - The brand has strengthened partnerships with major e-commerce platforms and is expanding its physical store presence, focusing on quality over quantity in store openings [7]. Group 7: Marketing and Brand Building - All Cotton Era prioritizes brand building over speed, employing a long-term marketing strategy that emphasizes brand value and consumer engagement through various promotional activities [9]. - The company focuses on high-quality content and precise advertising strategies to enhance brand recognition and drive sustainable business growth [9].

Core Viewpoint - The personal care products sector experienced a slight increase of 0.49% on January 29, with Yanjiang Co., Ltd. leading the gains. The Shanghai Composite Index closed at 4157.98, up 0.16%, while the Shenzhen Component Index closed at 14300.08, down 0.3% [1]. Group 1: Stock Performance - Yanjiang Co., Ltd. (300658) closed at 18.36, with a significant increase of 11.95% and a trading volume of 578,400 shares [1]. - Baiya Co., Ltd. (003006) closed at 21.22, up 0.52%, with a trading volume of 36,900 shares [1]. - Zhongshun Jierou (002511) closed at 8.62, up 0.47%, with a trading volume of 247,400 shares [1]. - Runben Co., Ltd. (603193) closed at 23.93, up 0.38%, with a trading volume of 24,200 shares [1]. - HaoYue Nursing (6009509) closed at 31.13, up 0.10%, with a trading volume of 16,400 shares [1]. - Wanjian Medical (300888) closed at 36.41, down 0.19%, with a trading volume of 45,600 shares [1]. - Kela Co., Ltd. (301009) closed at 13.22, down 0.38%, with a trading volume of 33,900 shares [1]. - Liangmian Needle (600249) closed at 5.89, down 0.67%, with a trading volume of 121,400 shares [1]. - Beijia Clean (603059) closed at 33.90, down 0.82%, with a trading volume of 20,300 shares [1]. - Dengkang Oral (001328) closed at 39.98, down 1.33%, with a trading volume of 23,100 shares [1]. Group 2: Capital Flow - The personal care products sector saw a net inflow of 51.52 million yuan from main funds, while retail investors experienced a net outflow of 47.97 million yuan [2]. - The main funds' net inflow for Yanjiang Co., Ltd. was 73.97 million yuan, with retail investors showing a net outflow of 44.41 million yuan [3]. - Baiya Co., Ltd. had a main fund net inflow of 4.00 million yuan, while retail investors had a net outflow of 0.28 million yuan [3]. - HaoYue Nursing experienced a main fund net inflow of 2.95 million yuan, with retail investors showing a net outflow of 5.13 million yuan [3]. - Dengkang Oral had a main fund net inflow of 1.74 million yuan, while retail investors had a net outflow of 0.60 million yuan [3].